179 related articles for article (PubMed ID: 32544955)
1. [Ayahuasca - religion, life-style or drug?].
Neu P
Fortschr Neurol Psychiatr; 2020 Oct; 88(10):669-673. PubMed ID: 32544955
[TBL] [Abstract][Full Text] [Related]
2. Ayahuasca and the process of regulation in Brazil and internationally: implications and challenges.
Labate BC; Feeney K
Int J Drug Policy; 2012 Mar; 23(2):154-61. PubMed ID: 21856141
[TBL] [Abstract][Full Text] [Related]
3. Report on psychoactive drug use among adolescents using ayahuasca within a religious context.
Doering-Silveira E; Grob CS; de Rios MD; Lopez E; Alonso LK; Tacla C; Da Silveira DX
J Psychoactive Drugs; 2005 Jun; 37(2):141-4. PubMed ID: 16149326
[TBL] [Abstract][Full Text] [Related]
4. Safety and side effects of ayahuasca in humans--an overview focusing on developmental toxicology.
dos Santos RG
J Psychoactive Drugs; 2013; 45(1):68-78. PubMed ID: 23662333
[TBL] [Abstract][Full Text] [Related]
5. Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution.
Uthaug MV; van Oorsouw K; Kuypers KPC; van Boxtel M; Broers NJ; Mason NL; Toennes SW; Riba J; Ramaekers JG
Psychopharmacology (Berl); 2018 Oct; 235(10):2979-2989. PubMed ID: 30105399
[TBL] [Abstract][Full Text] [Related]
6. Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness.
Hamill J; Hallak J; Dursun SM; Baker G
Curr Neuropharmacol; 2019; 17(2):108-128. PubMed ID: 29366418
[TBL] [Abstract][Full Text] [Related]
7. Ayahuasca use in cross-cultural perspective.
de Rios MD; Grob CS
J Psychoactive Drugs; 2005 Jun; 37(2):119-21. PubMed ID: 16149322
[No Abstract] [Full Text] [Related]
8. Altered states of consciousness and short-term psychological after-effects induced by the first time ritual use of ayahuasca in an urban context in Brazil.
Barbosa PC; Giglio JS; Dalgalarrondo P
J Psychoactive Drugs; 2005 Jun; 37(2):193-201. PubMed ID: 16149333
[TBL] [Abstract][Full Text] [Related]
9. Ayahuasca: What Healthcare Providers Need to Know.
Goldin D; Salani D
J Addict Nurs; 2021 Apr-Jun 01; 32(2):167-173. PubMed ID: 34060770
[TBL] [Abstract][Full Text] [Related]
10. Health status of ayahuasca users.
Barbosa PC; Mizumoto S; Bogenschutz MP; Strassman RJ
Drug Test Anal; 2012; 4(7-8):601-9. PubMed ID: 22761152
[TBL] [Abstract][Full Text] [Related]
11. The globalization of ayahuasca: harm reduction or benefit maximization?
Tupper KW
Int J Drug Policy; 2008 Aug; 19(4):297-303. PubMed ID: 18638702
[TBL] [Abstract][Full Text] [Related]
12. [Ayahuasca in the Netherlands: what the doctor should know about its side effects].
van den Berg A; van Eeghen EE; Kooter AJ; Tuinman TH; Tuinman PR
Ned Tijdschr Geneeskd; 2020 Aug; 164():. PubMed ID: 32940978
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of creative expression and entoptic phenomena as after-effects of repeated ayahuasca ceremonies.
Frecska E; Móré CE; Vargha A; Luna LE
J Psychoactive Drugs; 2012; 44(3):191-9. PubMed ID: 23061318
[TBL] [Abstract][Full Text] [Related]
14. Consumption of ayahuasca by children and pregnant women: medical controversies and religious perspectives.
Labate BC
J Psychoactive Drugs; 2011; 43(1):27-35. PubMed ID: 21615005
[TBL] [Abstract][Full Text] [Related]
15. Ayahuasca in adolescence: a neuropsychological assessment.
Doering-Silveira E; Lopez E; Grob CS; de Rios MD; Alonso LK; Tacla C; Shirakawa I; Bertolucci PH; Da Silveira DX
J Psychoactive Drugs; 2005 Jun; 37(2):123-8. PubMed ID: 16149323
[TBL] [Abstract][Full Text] [Related]
16. Ayahuasca in adolescence: a preliminary psychiatric assessment.
Da Silveira DX; Grob CS; de Rios MD; Lopez E; Alonso LK; Tacla C; Doering-Silveira E
J Psychoactive Drugs; 2005 Jun; 37(2):129-33. PubMed ID: 16149324
[TBL] [Abstract][Full Text] [Related]
17. Ayahuasca and Public Health: Health Status, Psychosocial Well-Being, Lifestyle, and Coping Strategies in a Large Sample of Ritual Ayahuasca Users.
Ona G; Kohek M; Massaguer T; Gomariz A; Jiménez DF; Dos Santos RG; Hallak JEC; Alcázar-Córcoles MÁ; Bouso JC
J Psychoactive Drugs; 2019; 51(2):135-145. PubMed ID: 30732540
[TBL] [Abstract][Full Text] [Related]
18. Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges.
McKenna DJ
Pharmacol Ther; 2004 May; 102(2):111-29. PubMed ID: 15163593
[TBL] [Abstract][Full Text] [Related]
19. Medicine, religion and ayahuasca in Catalonia. Considering ayahuasca networks from a medical anthropology perspective.
Apud I; Romaní O
Int J Drug Policy; 2017 Jan; 39():28-36. PubMed ID: 27768991
[TBL] [Abstract][Full Text] [Related]
20. Autonomic, neuroendocrine, and immunological effects of ayahuasca: a comparative study with d-amphetamine.
Dos Santos RG; Valle M; Bouso JC; Nomdedéu JF; Rodríguez-Espinosa J; McIlhenny EH; Barker SA; Barbanoj MJ; Riba J
J Clin Psychopharmacol; 2011 Dec; 31(6):717-26. PubMed ID: 22005052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
